Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2021
WEE1 Dependency and Pejorative Prognostic Value in Triple-Negative Breast CancerAlexandre de Nonneville, Pascal Finetti, Daniel Birnbaum, et al.
Journal of Clinical Medicine|May 5, 2019
<i>XPO1</i> Expression Is a Poor-Prognosis Marker in Pancreatic AdenocarcinomaDavid Jérémie Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.
Cancers|April 11, 2019
Head and Body/Tail Pancreatic Carcinomas Are Not the Same TumorsDavid Jérémie Birnbaum, François Bertucci, Pascal Finetti, et al.
Molecular Cancer|November 8, 2017
Validation and comparison of the molecular classifications of pancreatic carcinomasDavid J Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|March 3, 2018
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancerDavid J Birnbaum, François Bertucci, Pascal Finetti, et al.
Omics : a Journal of Integrative Biology|January 20, 2007
Gene expression profiling and clinical outcome in breast cancerFrançois Bertucci, Pascal Finetti, Nathalie Cervera, et al.
Breast Cancer Research and Treatment|August 4, 2014
ESPL1 is a candidate oncogene of luminal B breast cancersPascal Finetti, Arnaud Guille, José Adelaide, et al.
Computer Methods and Programs in Biomedicine|February 22, 2023
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkersCélestin Bigarré, François Bertucci, Pascal Finetti, et al.
Bioinformatics (Oxford, England)|January 13, 2012
Interactome-transcriptome integration for predicting distant metastasis in breast cancerMaxime Garcia, Raphaelle Millat-Carus, François Bertucci, et al.
Oncoimmunology|October 25, 2019
<i>PDL1</i> expression is associated with longer postoperative, survival in adrenocortical carcinomaEmilien Billon, Pascal Finetti, Alexandre Bertucci, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2021
WEE1 Dependency and Pejorative Prognostic Value in Triple-Negative Breast CancerAlexandre de Nonneville, Pascal Finetti, Daniel Birnbaum, et al.
Journal of Clinical Medicine|May 5, 2019
<i>XPO1</i> Expression Is a Poor-Prognosis Marker in Pancreatic AdenocarcinomaDavid Jérémie Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.
Cancers|April 11, 2019
Head and Body/Tail Pancreatic Carcinomas Are Not the Same TumorsDavid Jérémie Birnbaum, François Bertucci, Pascal Finetti, et al.
Molecular Cancer|November 8, 2017
Validation and comparison of the molecular classifications of pancreatic carcinomasDavid J Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|March 3, 2018
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancerDavid J Birnbaum, François Bertucci, Pascal Finetti, et al.
Omics : a Journal of Integrative Biology|January 20, 2007
Gene expression profiling and clinical outcome in breast cancerFrançois Bertucci, Pascal Finetti, Nathalie Cervera, et al.
Breast Cancer Research and Treatment|August 4, 2014
ESPL1 is a candidate oncogene of luminal B breast cancersPascal Finetti, Arnaud Guille, José Adelaide, et al.
Computer Methods and Programs in Biomedicine|February 22, 2023
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkersCélestin Bigarré, François Bertucci, Pascal Finetti, et al.
Bioinformatics (Oxford, England)|January 13, 2012
Interactome-transcriptome integration for predicting distant metastasis in breast cancerMaxime Garcia, Raphaelle Millat-Carus, François Bertucci, et al.
Oncoimmunology|October 25, 2019
<i>PDL1</i> expression is associated with longer postoperative, survival in adrenocortical carcinomaEmilien Billon, Pascal Finetti, Alexandre Bertucci, et al.
Pageof 18